Although it has been suggested that the increased FABP5 may interact with the increased level of PPARγ in a coordinated way to facilitate malignant progression of prostate cancer cells [20], the exact role of PPARγ in tumorigenicity of prostate cancer is not clear. The gene discussed is PPARG; the disease is prostate cancer.